A few of my friends have atrial fibrillation, often referred to as Afib. This is a condition where the heart’s upper chamber beats irregularly and fast. It can cause dizziness, fatigue, chest pain and ...

A randomized clinical trial found that among people with a history of Atrial fibrillation (AFib) or related rhythm issues, drinking at least one cup of caffeinated coffee daily was associated with a ...

Researchers from the Chinese Institute for Brain Research, the Chinese Academy of Medical Sciences, and their collaborators have identified adenosine as the driving force behind the rapid, fast-acting ...

Moderate coffee consumption may reduce AF recurrence risk post-cardioversion, contradicting traditional advice to avoid caffeine. The DECAF trial showed a 39% lower recurrence risk in coffee drinkers ...

Patients with irregular heartbeats — caused by atrial fibrillation (AF), the most common heart rhythm disorder — have historically been warned to limit or eliminate caffeine. But a new study suggests ...

Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine ...

The coffee paradox in adenosine-mediated antidepressant action. Depression (left) and coffee consumption (right) are both linked through adenosine signaling (center), creating a pharmacological ...

New research finds that daily coffee drinking may cut AFib risk by nearly 40%, defying decades of medical caution. Scientists discovered that caffeine’s effects on activity, blood pressure, and ...

Drinking coffee can protect against atrial fibrillation (A-Fib), a common heart rhythm disorder that causes a rapid, irregular heartbeat and can lead to stroke and heart failure. Doctors typically ...

Severe combined immunodeficiency (SCID) due to adenosine deaminase (ADA) deficiency (ADA-SCID) is an ultrarare genetic disease that results in the accumulation of toxic adenine metabolites that ...

Migliavacca M, Barzaghi F, Fossati C, et al. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. Nat Med 2024;30:488-497.